Detection of activin A and follistatin as potential biomarkers in women with ovarian endometriosis
Observational
OA: closed
public-domain-us
AI-generated summary
This study found significantly elevated levels of activin A and follistatin in women with ovarian endometriosis compared to healthy controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a condition characterized by the growth of tissue similar to the uterine lining outside the uterus. This study aimed to evaluate certain sex hormones and determine the levels of activin A and follistatin in women with endometriosis. The study included 45 women with ovarian endometriosis and 45 healthy women as a control group. Hormone levels were measured using a VIDAS analyzer (bioMérieux, France), while activin A and follistatin levels were estimated using ELISA (BT LAB). The baseline characteristics (age, weight, BMI, WHR, WHtR, education, and residency) of the patients were comparable to those in controls (P > 0.05). Similarly, there was no difference in LH and prolactin levels (P > 0.05). Patients with endometriosis had significantly higher FSH (7.17 ± 1.76 vs. 5.99 ± 2.22, P = 0.010) and estradiol levels (136.67 ± 27.27 vs. 57.84 ± 15.16, P < 0.001), while progesterone (0.35 ± 0.11 vs. 0.44 ± 0.16, P = 0.045), testosterone [0.69 (0.45-0.82) vs. 0.81 (0.73-0.88), P = 0.001], and AMH [0.24 (0.15-0.36) vs. 4.08 (2.42-7.34), P = 0.001] were significantly lower. Activin A [11.24 (11.02-11.81) vs. 1.26 (1.02-2.11), P < 0.001] and follistatin [23.36 (19.53-46.86) vs. 12.40 (8.81-18.93), P < 0.001] were markedly elevated in patients compared to controls. The results for Activin A and Follistatin also showed a significant increase, indicating their potential use as promising biomarkers in the diagnosis of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (29)
- Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes via openalex
- High serum follistatin levels in women with ovarian endometriosis via openalex
- Impact of endometriosis on the ovarian follicles via openalex
- Peritoneal Endometriosis Impairs Ovarian Reserve and Increases Atresia in a Rat Model via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Serum markers for the noninvasive diagnosis of endometriosis via openalex
- The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study via openalex
- W4401429470 via openalex
- W4402369061 via openalex
- W4403007827 via openalex
- W4403480737 via openalex
- W4404204872 via openalex
- W4404378485 via openalex
- W4404515493 via openalex
- W4408186283 via openalex
- W1543707496 via openalex
- W4413105490 via openalex
- W1991404560 via openalex
- W2002530713 via openalex
- W2033021374 via openalex
- W3194419458 via openalex
- W4212842994 via openalex
- W4234160457 via openalex
- W4379469062 via openalex
- W4380792625 via openalex
- W4387454801 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-10-23T06:08:06.940705+00:00
- openalex
- last seen: 2026-07-24T06:09:49.243201+00:00
- pubmed
- last seen: 2026-10-23T06:02:49.320619+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine